Back
Microsoft Vs. Lyra Therapeutics Sector Stock Comparison
Buy
64
MSFT
Microsoft
Last Price:
$485.90
Seasonality Move:
1.98%
Sell
39
LYRA
Lyra Therapeutics
Last Price:
$11.52
Seasonality Move:
12.18%
Sell
39
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $10.45. The Score for LYRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $10.45The current trend is relatively stagnant and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.
MSFT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.53 | Buy |
Relative Strength Index (14 RSI): | 68.96 | Buy |
Chaikin Money Flow: | -31532082 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (455.85 - 474.63) | Buy |
Bollinger Bands (100): | (380.64 - 450.96) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.97 | Buy |
Relative Strength Index (14 RSI): | 47.39 | Sell |
Chaikin Money Flow: | -31350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.11 - 18.91) | Sell |
Bollinger Bands (100): | (4.01 - 12.99) | Buy |
MSFT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 476.52 | Buy |
20-day SMA: | 467.7 | Buy |
50-day SMA: | 435.12 | Buy |
200-day SMA: | 420.87 | Buy |
8-day EMA: | 476 | Buy |
20-day EMA: | 467.03 | Buy |
50-day EMA: | 444.9 | Buy |
200-day EMA: | 421.38 | Buy |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.87 | Sell |
20-day SMA: | 13.08 | Sell |
50-day SMA: | 8.25 | Buy |
200-day SMA: | 9.92 | Buy |
8-day EMA: | 12.16 | Sell |
20-day EMA: | 12.24 | Sell |
50-day EMA: | 10.07 | Buy |
200-day EMA: | 22.87 | Sell |
Microsoft Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.71 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Microsoft Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |